Biotech · Private company

Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company

Track this companyFree. Adds Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company to your Dealase workspace and tells you when its record changes.

Clinical trials11 recruiting or active

Pipeline programs1From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline1

LY5830966Phase 1 · Primary MyelofibrosisClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials1

A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)PHASE1 · RECRUITING · started Oct 3, 2024ClinicalTrials.gov NCT06343805 · fetched Nov 12, 2026